Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

ZEPU AI9 lower-limb exoskeleton gait training for walking difficulties

Official title: Feasibility, Safety and Efficacy of ZEPU AI9 Lower Limb Exoskeleton Rehabilitation Robot in Patients With Lower Limb Motor Dysfunction

Run by Bangladesh Medical University · NCT07750808 · Data updated 2026-11-12

This study tests whether the ZEPU AI9 exoskeleton can be safely and effectively added to standard rehabilitation to improve walking for adults with stroke, incomplete spinal cord injury, or gait problems after orthopedic surgery.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment36 (estimated)
SponsorBangladesh Medical University
Academic / other
Locations1 site (Dhaka)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedOctober 2026
Study endsDecember 2026
Registry record updatedSeptember 11, 2026
Trial IDNCT07750808 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 with recent motor impairment from stroke, incomplete spinal cord injury, or orthopedic surgery and who meet device and medical safety criteria.

Probably not a fit

Patients with complete spinal cord injury or contraindications to exoskeleton use may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares exoskeleton-assisted gait training plus standard rehabilitation to standard rehabilitation alone in adults with walking impairments due to stroke, incomplete spinal cord injury, or orthopedic surgery. It aims to assess safety (e.g., device-related adverse events), tolerability, and functional outcomes such as walking distance, speed, balance, and leg strength. The ZEPU-AI9 is a dual-leg, motorized exoskeleton that guides hip and knee movements and supports safe over-ground and in-clinic training, with built-in safety features and a supervised harness. Participants will be randomized to the exoskeleton group or usual care, and the program will be tailored to each person's size and abilities. The study addresses implementation in a low-to-middle-income country setting by evaluating practicality within Bangladeshi rehabilitation services.

Why it matters

Potential benefit: If successful, patients could see improved walking ability and more efficient access to high-quality gait training.

How similar studies have gone: Robotic-assisted gait training has shown benefits in similar populations, though this specific device and local implementation are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 and ≤ 60 years.
* Lower-limb motor dysfunction from one of the following: (a) stroke (onset 2-24 months), (b) incomplete spinal-cord injury (neurological level T12 and below, ASIA C or D), (c) orthopedic surgery (e.g., knee/hip replacement) with persistent gait impairment \> 3months post-surgery.
* Able to provide informed consent and understand instructions.
* Weight ≤ 100 kg (as per device spec) and height within device adjustable range (manufacturer spec).
* Medically stable and cleared by physician for exoskeleton use (no active infection, uncontrolled cardiac/respiratory disease, severe osteoporosis, uncontrolled epilepsy, untreated DVT) with necessary investigations.

Exclusion Criteria:

* Complete spinal cord injury with inability to bear any weight.
* Severe cognitive impairment (e.g., MMSE \< 24) preventing safe participation.
* Severe spasticity (Modified Ashworth Scale \> 3) in lower limbs.
* Unstable fractures, severe hip/knee contractures (\> 30° fixed flexion), severe osteoarthritis requiring imminent surgery.
* Uncontrolled cardiac arrhythmia, pacemaker incompatibility, or implanted electronic device incompatible with robot sensors.
* Pregnancy.

Where it's running

  • Bangladesh Medical University
    Dhaka, Bangladesh
    Recruiting

Study contacts

  • Principal investigator: Md. Abdus Shakoor, Ph.D. — Bangladesh Medical University
  • Study coordinator: Md. Abdus Shakoor, Ph.D.
  • Email: shakoorma@bmu.ac.bd
  • Phone: +8801819410080

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.